Author： Gartel Andrei L
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.2, 2010-02, pp. : 235-242
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Glioblastoma Multiforme Formation and EMT: Role of FoxM1 Transcription Factor
Current Pharmaceutical Design, Vol. 21, Iss. 10, 2015-03 ,pp. :
Access to resources
Recommend
The proteasome: a new `irrational' target for cancer treatment
Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. :
Proteasome Inhibitors: A New Perspective for Treating Autoimmune Diseases
Current Drug Targets, Vol. 13, Iss. 13, 2012-12 ,pp. :